A Phase I Study of the DNA-PK Inhibitor Peposertib in Combination with Radiotherapy with or without Cisplatin in Patients with Advanced Head and Neck Tumors

MLA

Samuels, M., et al. “A Phase I Study of the DNA-PK Inhibitor Peposertib in Combination with Radiotherapy with or without Cisplatin in Patients with Advanced Head and Neck Tumors.” International Journal of Radiation Oncology Biology Physics 118(2024)3, 743-756, 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1427182505&authtype=sso&custid=ns315887.

APA

Samuels, M., Falkenius, J., Bar-Ad, V., Dunst, J., Triest, B., Yachnin, J., Rodriguez-Gutierrez, A., Kuipers, M., You, X., Sarholz, B., Locatelli, G., Becker, A., & 0000-0001-9550-9050) Troost, E. G. C. (2024). A Phase I Study of the DNA-PK Inhibitor Peposertib in Combination with Radiotherapy with or without Cisplatin in Patients with Advanced Head and Neck Tumors. International Journal of Radiation Oncology Biology Physics 118(2024)3, 743-756.

Chicago

Samuels, M., J. Falkenius, V. Bar-Ad, J. Dunst, B. Triest, J. Yachnin, A. Rodriguez-Gutierrez, et al. 2024. “A Phase I Study of the DNA-PK Inhibitor Peposertib in Combination with Radiotherapy with or without Cisplatin in Patients with Advanced Head and Neck Tumors.” International Journal of Radiation Oncology Biology Physics 118(2024)3, 743-756. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1427182505&authtype=sso&custid=ns315887.